• NovaGen signed a non-binding term sheet for a proposed business combination with Nasdaq-listed Veea.
• The deal targets creation of NovaGen Health Networks, combining Veea’s cybersecure AI infrastructure with NovaGen’s regenerative-medicine platform.
• GeoNova Capital committed USD 10 million as lead investor, cornerstone institutional investor, and corporate adviser tied to the proposed transaction.
• Parties are working toward definitive documentation in the coming weeks, subject to customary closing conditions.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Veea Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: CL50922) on September 17, 2026, and is solely responsible for the information contained therein.